Skip to content

Randomized Controlled Trial of Integrated Early Palliative Care

Randomized Controlled Trial of Integrated Early Palliative Care for Advanced Cancer Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03181854
Enrollment
144
Registered
2017-06-09
Start date
2017-09-08
Completion date
2019-06-30
Last updated
2019-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Cancer, Solid Tumor

Keywords

Integrated Early Palliative Care

Brief summary

This study verifies whether integrated Early Palliative Care for advanced cancer patients diagnosed due to a solid tumor improve quality of life and enhances the ability to overcome the current crisis.

Detailed description

Previous reports suggest that starting palliative care early in cancer patients appears to improve patient's quality of life, symptom management, depression, and anxiety. This study aims to evaluate the effect of the introduction of early palliative care services to advanced cancer patients. Eligible patients are 20 years or older, and has an advanced cancer diagnosis (histologically or cytologically confirmed) due to a solid tumor, a European Cooperative Oncology Group performance status of 0-2, an estimated life expectancy of 12 months or less. The primary goal of an integrated early palliative care program is to improve the overall quality of life of patients and their families. Secondarily, it is to help understand the disease, resolving conflicts in the decision-making process, improving the crisis coping capacity, and further determining the patient's and family's advanced care planning. At last, it is desired to evaluate the effect of the program on overall medical cost savings and 1 year survival. Participants of the study will be allocated in the intervention group and the control group equally. Within three weeks from the time of randomization, the first meeting with a palliative care team will be held. In the time of baseline questionnaire, patients will be provided with self-study education materials and videos on the early palliative care and advance care planning. Once in every three weeks for six months, which is the duration for one treatment course, palliative care for advance care planning, symptom control, and other mental, social and spiritual problems will be provided. After the first meeting with the palliative care team, telephone coaching will be performed once a week for the first 12 weeks and then every two weeks until the end of the study.

Interventions

Telephone coaching about overcoming the crisis is provided once a week for 3 months and once in 2 weeks for another 3 months.

BEHAVIORALConsultation with PCT doctor

Consultation with PCT physician every 3 weeks.

Sponsors

National Evidence-Based Healthcare Collaborating Agency
CollaboratorOTHER_GOV
National Institute of Health, Korea
CollaboratorOTHER_GOV
National Clinical Research Coordination Center, Seoul, Korea
CollaboratorOTHER_GOV
Seoul National University Bundang Hospital
CollaboratorOTHER
Severance Hospital
CollaboratorOTHER
Gyeongsang National University Hospital
CollaboratorOTHER
Chungnam National University Hospital
CollaboratorOTHER
Chonbuk National University Hospital
CollaboratorOTHER
Daegu Fatima Hospital
CollaboratorOTHER
Hallym University Medical Center
CollaboratorOTHER
Korea University Guro Hospital
CollaboratorOTHER
Asan Medical Center
CollaboratorOTHER
Chonnam National University Hospital
CollaboratorOTHER
Ewha Womans University Mokdong Hospital
CollaboratorOTHER
Keimyung University Dongsan Medical Center
CollaboratorOTHER
Ulsan University Hospital
CollaboratorOTHER
Pohang Semyeong Christianity Hospital
CollaboratorUNKNOWN
Gangneung Asan Hospital
CollaboratorOTHER
Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject 20 years and older. * Subject who has an advanced cancer diagnosis (histologically or cytologically confirmed) due to a solid tumor * Subject whose ECOG performance status is between 0 to 2. * Subject with an estimated life expectancy of 12 months and less (assessed by the treating oncologist) * Subject who volunteers

Exclusion criteria

* Inability to speak, understand or write Korean. * Medical conditions that would limit adherence to participation of the clinical trial(as confirmed by their referring physician; e.g. dyspnea) * Suspension of all cancer treatment * Palliative care consultation at any time or in palliative care

Design outcomes

Primary

MeasureTime frameDescription
Change in level of EORTC QLQ-C15-PALbaseline, 12 weeks, 18 weeks, 24 weeksA questionnaire developed to assess the quality of life of palliative cancer care patients.

Secondary

MeasureTime frameDescription
Change in level of EQ-5D of EuroQoLBaseline, 12 weeks, 18 weeks, 24 weeksA questionnaire that measures mobility, self-care, daily activity, pain/discomfort, and anxiety/depression.
Change in level of PHQ-9Baseline, 12 weeks, 18 weeks, 24 weeks9-question instrument given to patients in a primary care setting to screen for the presence and severity of depression.
Change in level of Understanding the illnessBaseline, 12 weeks, 18 weeks, 24 weeks2 questions to assess how patients understand the prognosis of their illness
Change in level of Crisis Overcoming Capability(SAT-SF)Baseline, 12 weeks, 18 weeks, 24 weeksA questionnaire about goal of life, current crisis/goal, positivity, preparation and practice.
Change in Advance Care PreferenceBaseline, 12 weeks, 18 weeks, 24 weeksQuestions about advance directive and treatment preference in case of terminal condition
Medical cost and utilization of CAM12 weeks, 24 weeksOverall medical cost savings (cost effectiveness) and use of complementary and alternative medicine
Change in level of MQOLBaseline, 12 weeks, 18 weeks, 24 weeksA questionnaire that measures psychological, existential well-being, and support.
Changes of CQOLBaseline, 12 weeks, 18 weeks, 24 weeksA questionnaire that measures quality of life and burden for family caregivers
Change in level of PHQ-9 of family caregiversBaseline, 12 weeks, 18 weeks, 24 weeks9-question instrument given to caregivers in a primary care setting to screen for the presence and severity of depression.
Change in level of Understanding the illness of family caregiversBaseline, 12 weeks, 18 weeks, 24 weeks2 questions to assess how family caregivers understand the prognosis of patients' illness
Change in level of Crisis Overcoming Capability(SAT-SF) of family caregiversBaseline, 12 weeks, 18 weeks, 24 weeksA questionnaire about goal of life, current crisis/goal, positivity, preparation and practice of family caregivers.
Change in Advance Care Preference of family caregiversBaseline, 12 weeks, 18 weeks, 24 weeksQuestions about family caregivers' preference on advance directive and treatment in case of terminal condition
Change in Quality Care QuestionnaireBaseline, 12 weeks, 3 months after deathThe 4-factor, 32-item Quality Care Questionnaire-Palliative Care (QCQ-PC), which covers appropriate communication with health care professionals (ten items), discussing value of life and goals of care (nine items), support and counseling for needs of holistic care (seven items), and accessibility and sustainability of care (six items).
1 year survival1 year1 year survival

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026